Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Simavita is a digital healthcare company specializing in the development of smart technology for the management of incontinence. Its flagship product, SIM™ (Smart Incontinence Management), is a wireless sensor-based system that automates the recording of incontinence events to create evidence-based assessments. This technology is primarily used in aged care facilities to improve resident outcomes, optimize staffing, and reduce costs associated with manual charting. The company's platform integrates wearable sensors, software, and data analytics to provide real-time insights into bladder and bowel health. Headquartered in Australia, Simavita aims to transform the standard of care for the elderly through data-driven clinical insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Simavita.